Physician profile
David E Paden
NPI 1295755866
$977.74
in general payments reported to CMS, 2019-2025
11 companies · $66.77 in 2025
The $66.77 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $63.28 · 2021: $54.60 · 2022: $207 · 2023: $220 · 2025: $66.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $328.60 | 2019-2023 | Total30, Rocklatan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2019 | |
| Coopervision INC. | $97.32 | 2019-2023 | Myday Contact Lens |
| Oyster Point Pharma, INC. | $94.08 | 2022-2023 | Tyrvaya |
| Abbvie INC. | $80.29 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $77.22 | 2022-2025 | Infuse, Vyzulta |
| Novartis Pharmaceuticals Corporation | $72.22 | 2021-2023 | |
| Johnson & Johnson Vision Care, INC. | $38.94 | 2022-2023 | Acuvue |
| Rayner Intraocular Lenses Limited | $29.98 | 2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Carl Zeiss Meditec Ag | $17.20 | 2020 | |
| Allergan, INC. | $16.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Paden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.